These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Statins and endothelial dysfunction. Larose E; Ganz P Semin Vasc Med; 2004 Nov; 4(4):333-46. PubMed ID: 15861315 [TBL] [Abstract][Full Text] [Related]
4. Antioxidative effects of statins. Adam O; Laufs U Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762 [TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular mechanisms of statins: an update on pleiotropic effects. Satoh M; Takahashi Y; Tabuchi T; Minami Y; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M Clin Sci (Lond); 2015 Jul; 129(2):93-105. PubMed ID: 25927679 [TBL] [Abstract][Full Text] [Related]
6. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes]. Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071 [TBL] [Abstract][Full Text] [Related]
7. Microcirculation as a target for the anti-inflammatory properties of statins. Scalia R; Stalker TJ Microcirculation; 2002 Dec; 9(6):431-42. PubMed ID: 12483541 [TBL] [Abstract][Full Text] [Related]
8. Pleiotropic effects of statins. Liao JK; Laufs U Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172 [TBL] [Abstract][Full Text] [Related]
9. Effects of statins on endothelium and endothelial progenitor cell recruitment. Walter DH; Dimmeler S; Zeiher AM Semin Vasc Med; 2004 Nov; 4(4):385-93. PubMed ID: 15861319 [TBL] [Abstract][Full Text] [Related]
10. Potential vascular benefits of statins. Kinlay S Am J Med; 2005 Dec; 118 Suppl 12A():62-7. PubMed ID: 16356810 [TBL] [Abstract][Full Text] [Related]
11. Recent developments in the effects of nitric oxide-donating statins on cardiovascular disease through regulation of tetrahydrobiopterin and nitric oxide. Ma S; Ma CC Vascul Pharmacol; 2014 Nov; 63(2):63-70. PubMed ID: 25139660 [TBL] [Abstract][Full Text] [Related]
12. Pathological changes in acute coronary syndromes: the role of statin therapy in the modulation of inflammation, endothelial function and coagulation. Ray KK; Cannon CP J Thromb Thrombolysis; 2004 Oct; 18(2):89-101. PubMed ID: 15789175 [TBL] [Abstract][Full Text] [Related]
14. The effects of statins on endothelium, inflammation and cardioprotection. Elrod JW; Lefer DJ Drug News Perspect; 2005 May; 18(4):229-36. PubMed ID: 16034478 [TBL] [Abstract][Full Text] [Related]
15. Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering. Margaritis M; Channon KM; Antoniades C Antioxid Redox Signal; 2014 Mar; 20(8):1198-215. PubMed ID: 24111702 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of pleiotropic effects of statins: lipid reduction and beyond. Auer J; Berent R; Weber T; Eber B Curr Med Chem; 2002 Oct; 9(20):1831-50. PubMed ID: 12369881 [TBL] [Abstract][Full Text] [Related]
17. The nonlipid effects of statins on endothelial function. Beckman JA; Creager MA Trends Cardiovasc Med; 2006 Jul; 16(5):156-62. PubMed ID: 16781949 [TBL] [Abstract][Full Text] [Related]
18. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering. Marzilli M Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728 [TBL] [Abstract][Full Text] [Related]
19. Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins? Balakumar P; Kathuria S; Taneja G; Kalra S; Mahadevan N J Mol Cell Cardiol; 2012 Jan; 52(1):83-92. PubMed ID: 21968328 [TBL] [Abstract][Full Text] [Related]
20. Statins and the endothelium. Ii M; Losordo DW Vascul Pharmacol; 2007 Jan; 46(1):1-9. PubMed ID: 16920035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]